Yatharth Hospital & Trauma Care Services Limited
BSE: 543950 | NSE: YATHARTH
Sector: Healthcare | Industry: Hospital
ABOUT COMPANY
Yatharth Hospital & Trauma Care Services Limited (hereafter referred to as ‘Yatharth’ or ‘the Company’) was incorporated on February 28, 2008 in Delhi NCR by Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar and converted into a public company on November 18, 2021, according to RoC.
Yatharth started its journey with single facility in the Delhi NCR region and has since evolved into a prominent healthcare network in North India. The company is running a chain of multi speciality hospitals which offers various services including oncology, cardiac sciences, neurosciences, renal care and more. The company is strategically focused on high density micro market in North India – National Capital Region (NCR) and the Jhansi–Orchha region – which allows the company to leverage strong brand recall, established clinician networks and referral channels.
Yatharth generates revenue broadly in 3 ways, i.e. healthcare services, pharmaceutical supplies and consultation fees.
Earning Calls Summary
Q2 Revenue Surges 52%; Advent's ₹3,150 Cr to Fund 7,000-8,000 Bed Ambition
Management opened describing Q2 FY27 as the strongest quarter to date, noting that since listing in August 2023, Yatharth has more than doubled capacity from 1,405 to ~2,800 beds while tripling revenues and profits. The Advent partnership brings over 35 years of healthcare investment experience and long-term capital to accelerate growth.
The research report presented here is for informational and research purposes only. It reflects our own views, assumptions, and analysis and is not intended as a recommendation, offer, or solicitation to buy, sell, or hold any security or asset. Please conduct your own due diligence and consult a qualified financial advisor before making any investment decision. Please check our Terms & Conditions page before investing.